Bristol Myers Squibb reported strong second-quarter earnings, surpassing Wall Street expectations and raising its full-year guidance as part of its broader strategy to cut costs and...
Etiket: Bristol Myers Squibb
Medicare Drug Price Negotiations: Short-Term Stability, Long-Term Concerns for Pharma
The conclusion of the first round of Medicare drug price negotiations marks a significant milestone, though the final negotiated prices for the selected medications remain undisclosed....